세계의 뇌종양 치료제 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규모 추이·예측, 각종 구분·지역별 상세 분석 등을 정리하여 전해드립니다.
목차
제1장 개요
시장 전망
조사 범위
시장 요약
시장 역학과 성장요인
신규 기술
부문 분석
지역 분석
결론
제2장 시장 개요
개요
거시경제 요인 분석
미국 관세의 제약 업계에 대한 영향
의료비
세계의 경제성장이 제약 업계에 미치는 영향
Porter's Five Forces 분석
제3장 시장 역학
시장 역학
시장 성장 촉진요인
뇌종양 증례의 증가
기업에 의한 연구개발비의 확대
정부 자금 및 제약 연구개발비의 증가
시장 성장 억제요인
뇌종양에 대한 치료 옵션의 부족
뇌종양 치료제의 고비용
뇌종양의 낮은 검진율
시장 기회
바이오시밀러 및 제네릭 의약품의 보급 확대
공동 연구
제4장 규제 상황
규제 역학
미국
유럽
아시아태평양
제5장 신규 기술과 파이프라인 분석
신규 동향·기술
AI
바이오마커
파이프라인 분석
특허 분석
제6장 시장 부문 분석
세분화 내역
세계의 뇌종양 치료제 시장 : 치료 유형별
주요 포인트
화학요법
표적치료
면역치료
세계의 뇌종양 치료제 시장 : 환자 연령별
주요 포인트
성인
소아
세계의 뇌종양 치료제 시장 : 최종사용자별
주요 포인트
병원
홈케어
지역적 내역
세계의 뇌종양 치료제 시장 : 지역별
주요 포인트
북미
유럽
아시아태평양
남미
중동 및 아프리카
제7장 경쟁 정보
주요 포인트
경쟁 구도
기업 점유율 분석
제8장 뇌종양 치료에서의 지속가능성 : ESG의 관점
ESG : 서론
뇌종양 치료제 시장에서의 지속가능성
ESG의 시점
환경에 대한 영향
사회에 대한 영향
거버넌스의 영향
ESG 리스크 평가
결론
제9장 부록
조사 방법
약어
전시
기업 개요
AMGEN INC.
AMNEAL PHARMACEUTICALS LLC.
BAXTER
BAYER AG
F. HOFFMANN-LA ROCHE LTD.
MERCK & CO. INC.
NOVARTIS AG
PFIZER INC.
SERVIER LABORATORIES
TEVA PHARMACEUTICAL INDUSTRIES LTD.
신규 기업·시장 디스럽터
KSA
영문 목차
영문목차
The report provides an analysis of brain tumor therapeutics and analyzes market trends. Using 2024 as the base year, the report provides estimated market data for 2025 through 2030. The market in this report is segmented by therapy type, patient age, end user, and region. The report covers regulatory scenarios, drivers, restraints, opportunities, and the market share for key companies.
Report Scope
This report provides detailed information on brain tumor therapeutics. It analyzes the market trends for brain tumor therapeutics with data from 2024, estimates from 2025, projections of compound annual growth rates through 2030 (forecast period 2025-2030) and regional markets for brain tumor therapeutics. This report highlights brain tumor therapeutics' current and future market potential and providess a detailed competitive environment analysis. The report covers regulatory scenarios, drivers, restraints and opportunities. It also covers market projections for 2030 and the market share for key companies.
This brain tumor therapeutics market is segmented by therapy type into chemotherapy, targeted therapy and immunotherapy. The patient age segment is segmented into adults and pediatrics. The end user segment is segmented into hospitals and home care settings.
The market has been segmented into the following major regions: North America, Europe, Asia-Pacific, the Middle East and Africa and South America. The regional segment covers a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia and India. For market estimates, 2024 is used as the base year, with forecasts for 2025 and a forecast value for 2030.
The report aims to:
Analyze types of brain tumors and related therapeutics.
Analyze global market size and segmentation.
Understand market constraints and drivers.
Provide detailed market forecasts for 2030.
Assess market shares, competitiveness and industry structure.
Identify potential long-term impacts on the brain tumor therapeutics market.
Report Includes
An overview of the current and future global market potential for brain tumor therapeutics
Analyses of the global market trends, with historical market revenue data from 2022 to 2024, estimates for 2025, and projections of CAGRs through 2030
Estimates of the market size and revenue growth prospects, along with a corresponding market share analysis by therapy type, patient age group, end user and region
Facts and figures pertaining to market dynamics, technological advances, regulations, prospects and the impacts of macroeconomic variables
Impact analysis of U.S. tariff laws, as well as use cases of AI adoption on the market
Insights derived from Porter's Five Forces model, as well as global supply chain and PESTLE analyses
Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
A relevant patent analysis, featuring key granted and published patents
Analysis of the industry structure, including companies' market shares and rankings, strategic initiatives, M&A activity and a venture funding outlook
Profiles of the leading companies
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview
Macroeconomic Factors Analysis
Impact of U.S. Tariffs on the Pharmaceutical Industry
Healthcare Expenditure
Impact of Global Economic Growth on the Pharma Sector
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Incidence of Brain Tumor Cases
Increasing R&D Spending by Market Players
Rise in Government Funding and Pharmaceutical R&D Spending
Market Restraints
Inadequate Treatment Options for Brain Tumors
High Cost of Brain Cancer Drugs
Low Screening of Brain Tumors
Market Opportunities
Increasing Availability of Biosimilars and Generics
Research Collaborations
Chapter 4 Regulatory Landscape
Regulatory Dynamics
U.S.
Europe
Asia-Pacific
Chapter 5 Emerging Technologies and Pipeline Analysis
Emerging Trends/Technologies
Artificial Intelligence
Biomarkers
Pipeline Analysis
Key Takeaways
Patent Analysis
Key Takeaways
Chapter 6 Market Segment Analysis
Segmentation Breakdown
Global Brain Tumor Therapeutics Market, by Therapy Type
Key Takeaways
Chemotherapy
Targeted Therapy
Immunotherapy
Global Brain Tumor Therapeutics Market, by Patient Age
Key Takeaways
Adults
Pediatric
Global Brain Tumor Therapeutics Market, by End User
Key Takeaways
Hospitals
Home Care
Geographic Breakdown
Global Brain Tumor Therapeutics Market, by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Landscape
Company Share Analysis
Chapter 8 Sustainability in Brain Tumor Therapeutics: ESG Perspective
Introduction to ESG
Sustainability in the Brain Tumor Therapeutics Market
